Papillary fibroelastoma (PFE) is the second most common primary benign cardiac tumor and the most common cardiac valvular tumor. Over 80% arise on valve leaflets, particularly the aortic valve (44%) and mitral valve (35%). It typically presents as a small (<1.5 cm), pedunculated, round mass with characteristic 'sea anemone' appearance due to papillary projections on its surface. Histopathologically, it consists of avascular papillae covered by an endothelial layer; each papilla has a stromal core containing elastin, collagen, and mucopolysaccharides. Its clinical significance stems from the risk of stroke and systemic embolic events due to surface thrombus formation — embolic events have been reported in 30% of asymptomatic patients.
Age Range
40-80
Peak Age
60
Gender
Equal
Prevalence
Rare
The pathogenesis of papillary fibroelastoma is not fully elucidated, and reactive (endothelial damage and organization from turbulent flow), hamartomatous, or neoplastic origins have been proposed. The tumor consists of avascular papillary projections covered by endothelial cells, each containing a stromal core of elastin fibrils, collagen fibers, and acid mucopolysaccharide-rich loose connective tissue. Due to its avascular nature, contrast enhancement on MRI is minimal or absent — a critical feature for distinguishing it from vascularized tumors (myxoma). The surface of papillary projections is prone to thrombus formation; these fragile thrombus fragments detach and embolize to cerebral and peripheral arteries. In aortic valve PFE, the tumor may be positioned near the coronary ostium, potentially causing myocardial infarction from coronary embolism. Despite its small size, the high embolic potential results from the papillary surface structure's interaction with turbulent blood flow facilitating platelet activation.
The characteristic echocardiographic appearance (especially on TEE) of papillary fibroelastoma: numerous fine papillary projections (fronds) on the surface of a small round mass that gently sway in blood flow creating a 'sea anemone' or 'jellyfish'-like image. This morphology becomes even more apparent macroscopically when the tumor is immersed in water. It is a pathognomonic echocardiographic finding.
On transthoracic or transesophageal echocardiography, a small (typically 5-15 mm), well-circumscribed, round or oval, homogeneously echogenic, pedunculated mass on the valve leaflet. The tumor oscillates with valve motion and demonstrates characteristic 'shimmer/stippling' movement throughout the cardiac cycle. TEE provides higher resolution than TTE, showing papillary surface details and stalk fine details. The majority of tumors are located on the arterial surface of the valve (aortic side of aortic valve, atrial side of mitral valve).
Report Sentence
A pedunculated, mobile, round, homogeneously echogenic mass measuring _x_ mm is seen on the arterial surface of the aortic valve (right coronary cusp). Papillary surface projections are present ('sea anemone' appearance).
Color Doppler demonstrates no intrinsic vascularity within the tumor — this finding reflects the avascular histopathological structure of PFE and is important for differentiating from vascularized cardiac tumors (myxoma, sarcoma). If large lesions cause valve motion restriction, mild valvular regurgitation jets may be observed. For aortic valve tumors, proximity to the coronary ostium should be evaluated.
Report Sentence
Color Doppler demonstrates no intrinsic vascularity within the valve mass; consistent with avascular structure.
On ECG-gated contrast-enhanced CT, a small, round, low-density (30-50 HU) nodule on the valve leaflet. Shows no significant enhancement or minimal enhancement after contrast. The small size and valve-based location may make diagnosis challenging due to motion artifact; ECG-gating and retrospective reconstruction are critically important. CT is superior to echocardiography for evaluating tumor calcification and coronary artery relationship.
Report Sentence
On ECG-gated CT, a round nodular lesion measuring _x_ mm with low density and no enhancement is seen on the aortic valve.
On T1-weighted sequences, a homogeneous, small round mass isointense to myocardium on the valve leaflet. The tumor is clearly delineated against the bright blood signal background. Internal hemorrhage is rare (unlike myxoma). T1 signal reflects the collagen and elastin-rich structure.
Report Sentence
On T1-weighted sequences, a homogeneous round mass measuring _x_ mm isointense to myocardium is seen on the aortic valve.
On T2-weighted sequences, PFE shows iso-to-mildly hyperintense signal relative to myocardium. Unlike the marked T2 hyperintensity of myxoma, PFE has lower water content and less pronounced T2 signal. This difference is an important MR criterion for differential diagnosis between the two tumors. The homogeneous signal pattern reflects the rarity of internal complications (hemorrhage, necrosis).
Report Sentence
On T2-weighted sequences, the valve mass shows iso-to-mildly hyperintense homogeneous signal relative to myocardium.
On post-gadolinium sequences, PFE shows no enhancement or minimal enhancement. This finding confirms the avascular structure of the tumor and is the most valuable MR criterion for differentiation from vascularized tumors (myxoma, malignant tumors). On LGE sequences, it is identified as a hypodense/low-signal nodule different from surrounding valve tissue and blood pool.
Report Sentence
On post-gadolinium sequences, no enhancement is identified within the valve mass; consistent with avascular structure.
On cine SSFP sequences, a pedunculated, small, round mass is seen on the valve leaflet. The tumor oscillates synchronously with valve motion, moving on a short stalk. During diastole when the valve opens, the tumor swings toward the arterial (downstream) direction and returns in systole. Cine sequences are critical for dynamically assessing the relationship of the tumor to the coronary ostium in aortic valve lesions.
Report Sentence
On cine SSFP sequences, a pedunculated, mobile, oscillating small round mass is seen on the aortic valve. Relationship to the coronary ostium has been evaluated.
Criteria
Most common location (44%). Usually on aortic surface (downstream). Risk of coronary embolism and myocardial infarction due to proximity to left coronary ostium. Non-coronary cusp most commonly involved.
Distinct Features
Coronary embolism risk (8%), systemic embolism risk (TIA, stroke), surgical resection usually valve-sparing. Location on arterial surface of aortic valve typically does not impair valve function.
Criteria
Second most common location (35%). Usually on atrial surface. Anterior leaflet more commonly involved. High systemic embolism (especially cerebral) risk.
Distinct Features
Careful differential from myxoma — PFE on valve, myxoma on septum. PFE small and homogeneous, myxoma large and heterogeneous. Small nodule attached to atrial surface of mitral valve.
Criteria
10-15% of all PFEs are extravalvular: left ventricular endocardium, papillary muscles, chordae tendineae, right heart structures. Pre-operative diagnosis is more difficult due to atypical location.
Distinct Features
Small pedunculated mass on extravalvular endocardial surface. Embolic risk persists. Diagnostic difficulty on TEE — CMR is more valuable.
Distinguishing Feature
Myxoma is much larger (2-8 cm vs <1.5 cm), attached to septum (not valve), heterogeneous internal structure, markedly T2 hyperintense, shows heterogeneous enhancement. PFE is small, valve-based, homogeneous, iso-to-mildly T2 hyperintense, shows no enhancement.
Distinguishing Feature
Vegetation (endocarditis) is an irregular, amorphous, variably echogenic mass at the coaptation line (upstream surface) of the valve associated with fever, bacteremia, and valvular regurgitation. PFE is on the arterial surface (downstream), smoothly round, and clinically asymptomatic or presents with embolic events.
Distinguishing Feature
Lambl excrescences are very small (<3 mm), thin, filiform structures seen at the coaptation edge of the valve (usually aortic). PFE is larger (5-15 mm), round, pedunculated with papillary surface. Lambl excrescences are considered clinically insignificant, while PFE carries embolic risk.
Distinguishing Feature
Valve thrombus is usually irregular in shape, T2 hypointense, shows no enhancement, and shrinks with anticoagulant therapy. PFE is round, T2 iso-to-mildly hyperintense, and does not respond to anticoagulant therapy. Thrombus is usually associated with underlying valvular disease or hypercoagulability.
Urgency
urgentManagement
surgicalBiopsy
Not NeededFollow-up
6-monthPapillary fibroelastoma is clinically significant despite its size due to its high embolic potential. Surgical resection is recommended for PFE on left heart valves (especially mobile, pedunculated lesions) — prophylactic resection without waiting for embolic events is the current standard approach. Surgery involves excision of the tumor with its stalk using a 'valve-sparing' technique; valve replacement is rarely needed (5%). Conservative follow-up with anticoagulant therapy may be considered for right heart lesions or high surgical risk patients. Post-surgical recurrence is very rare (1%). Surgery is emergently indicated in patients who have had embolic events.
Papillary fibroelastoma is often discovered incidentally but has high clinical significance due to the risk of embolic complications (stroke, myocardial infarction, peripheral embolism). Surgical resection is recommended for left-sided valve lesions — valve-sparing shave excision is the standard approach, valve replacement is rarely needed. Conservative management with regular echocardiographic follow-up may be applied for asymptomatic, small (<1 cm), non-mobile right-sided lesions. Recurrence after surgery is extremely rare.